NewsEvents

Your Yourlocation: Home > Tiotropium bromide(136310-93-5) is only needed once a day

Tiotropium bromide(136310-93-5) is a long-acting drug that lasts up to 24 hours, so it is only needed once a day, which is very helpful in improving patient compliance. The so-called compliance is that patients can follow the doctor's advice program for treatment. So this makes the probability of patients medication significantly increased.

Long-acting beta-agonists (LABA) and long-acting muscarinic antagonists (LAMA) are recommended as first-line maintenance options in the treatment guidelines, and the combination of these two major bronchodilator drugs has been highly anticipated.

LAMAs have been validated in COPD, with the Boehringer Ingelheim-based product, tiotropium bromide(136310-93-5), with sales of $ 5 billion last year, but LAMA / LABA combination drugs are only available in recent years use.

This is one of the reasons respiratory experts believe LAMA / LABA will become a new force in the treatment of COPD, including Ultibro, GlaxoSmithKline and Anoro (Umeclidinium bromide) Ringer Ingelheim's tiotropium / Olodaterol (under registration), which, Anoro and Ultibro were approved last year.

Novartis also published the results of the QUANTIFY and GLISTEN studies at the European Respiratory Society, a QUANTIFY study showing that the product is superior to tiotropium bromide(136310-93-5) and formoterol, GLISTEN is investigating the addition of glycopyrrolate LABA / inhaled corticosteroid therapy.

Address:211#Zhengfeng Building,Huanbaokejiyuan, Gaoxinkaifaqu, Jinan,250100,China TEL:086-531-82375818 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved